Table 2.
HIV-OMH: sites affected and clinical characteristics.
| Clinical parameters | HIV-OMH (n = 37) | ||
|---|---|---|---|
| Intraoral site | Gingiva | 17 | 45.95% |
| Buccal mucosa | 11 | 29.73% | |
| Palate-hard | 6 | 16.22% | |
| Palate-soft | 2 | 5.41% | |
| Tongue | 6 | 16.22% | |
| Labial mucosa | 7 | 18.92% | |
| Floor of the mouth | 1 | 2.70% | |
| Alveolar ridge | 1 | 2.70% | |
|
| |||
| Extent | Localised/single | 3 | 8.11% |
| Generalised/multiple | 34 | 91.89% | |
|
| |||
| Intensity | Light | 20 | 54.05% |
| Dense | 17 | 45.95% | |